Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.

Drug–drug interactions with DOACs persist despite computerized alerts

Stephen Padilla
21 Apr 2020

Clinicians vary as to how they manage drug–drug interactions (DDIs) with direct oral anticoagulants (DOACs) in clinical practice, with potentially substantial DDIs with DOACs still occurring despite computerized alerts, according to a study.

“When major DDIs with a DOAC occur, the benefit–risk evaluation should be made based on clinical relevance of DDIs as well as patient-specific factors,” the researchers said.

This retrospective chart review was conducted at the Brookdale University Hospital and Medical Center (BUHMC) in New York, US, from January 2014 to November 2016. All adult patients admitted to the BUHMC who received a DOAC for at least 3 days were screened. Those who received selected interacting drugs at any time during DOAC therapy were eligible for the study.

A total of 165 patients (mean age, 73 years) and 233 cases were included. Aspirin (58 percent) was the most commonly used concomitant drug with a DOAC, followed by amiodarone (16 percent) and P2Y12 inhibitors (11 percent). [J Pharm Pract 2020;33:136-141]

Eighteen cases (6 percent) were identified to have used the combination of dual antiplatelet therapy and a DOAC. About a third of these cases were classified as the “avoidance” category.

Significant DDIs with DOACs occurred partly because of insufficient clinical data regarding DOAC DDIs, resulting in a wide variation across guideline recommendations, the researchers said. [J Thromb Thrombolysis 2016;41:206-232; Eur Heart J 2017;38:2137-2149; JCOM 2015;22:550-564]

“The mechanisms of DOAC DDIs mediated by P-gp and/or CYP3A4 are well described in the literature and widely understood among healthcare professionals,” they noted. “The incidence and clinical significance of these DDIs are not yet clearly established.” [Ther Adv Drug Saf 2017;8:319-328; Signa Vitae 2017;13(suppl 1):68-70]

This then led to a lack of consensus among international guidelines as well as drug information resources on how to manage clinically relevant DOAC DDIs. [Ther Adv Drug Saf 2017;8:319-328]

In a recent Australian study, Forbes and colleagues found that potential DDIs with DOACs were relatively common among inpatients aged >65 years (37 percent). This was consistent with the results of the current study, which found that potential DDIs with DOACs occurred in inpatients with an average age of 73 years (~30 percent). [Ther Adv Drug Saf 2017;8:319-328]

A retrospective study also found an increased risk of major bleeding when a DOAC was given with amiodarone, fluconazole, rifampin and phenytoin. The current study reported nearly 70 percent of patients receiving DOACs plus antiplatelet agents. [JAMA 2017;318:1250-1259]

According to the researchers, most patients who experienced significant bleeding events received antiplatelet agents concomitantly with DOACs.

“It would be reasonable for institutions to integrate key aspects from multiple clinical practice guidelines into practice until further studies provide conclusive evidence related to the appropriate use of DOACs including drug interactions,” they noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.